Diagnosing E. coli: Cultures, Dipstick, and Specialized Tests
When you have symptoms of a urinary tract infection, intestinal illness, or a more serious bloodstream infection, your doctor needs to know exactly which bacteria is causing the problem — and whether antibiotics will actually work against it. E. coli is the most common bacterial cause of UTIs and is also behind deadly outbreaks of bloody diarrhea. The right test at the right time can guide treatment, prevent kidney damage, and sometimes save a life. This page walks through every major diagnostic test used for E. coli infections, what the results mean, and what you as a patient can do to help get the most accurate result.
- Urine Dipstick: The First Quick Test
- Microscopic Urinalysis
- Urine Culture: The Gold Standard
- When to Get a Urine Culture vs. Just Treat
- Stool Culture for STEC and Intestinal E. coli
- Shiga Toxin Immunoassay
- Blood Cultures for Suspected Sepsis
- Detecting ESBL and Resistant E. coli in the Lab
- Key Research Papers
- Connections
- Featured Videos
Urine Dipstick: The First Quick Test
The urine dipstick is usually the very first test done when you walk into a clinic with UTI symptoms. It takes only a few minutes and gives a quick yes-or-no signal that guides whether your doctor treats you immediately or waits for more information.
The dipstick checks two things that matter for bacterial infection:
- Nitrite test: Most gram-negative bacteria — including E. coli — naturally convert nitrate (a normal compound in urine from your diet) into nitrite. The dipstick pad turns pink or red when nitrite is present. A positive nitrite test is a strong indicator that bacteria are present. The key word is "most" — some bacteria that cause UTIs do not convert nitrate, so a negative result does not mean you're infection-free.
- Leukocyte esterase (LE) test: White blood cells (neutrophils) release an enzyme called leukocyte esterase when they're fighting an infection. A positive LE test means your body is mounting an inflammatory response in your urinary tract — consistent with infection, though it can also be positive from non-infectious causes like kidney stones or contaminated samples.
Together, the nitrite and LE tests have roughly 75% sensitivity and 82% specificity for detecting a UTI. Translated into plain language: the dipstick catches about three in four real infections (it misses one in four), and about four in five positive results are genuine infections (one in five are false alarms).
Why a negative dipstick doesn't rule it out: Several situations produce false-negative results. If you drank a lot of water recently, your urine is diluted, reducing both nitrite concentration and bacterial density below the detection threshold. If you haven't held your urine very long (bacteria need time — typically two or more hours in the bladder — to convert enough nitrate), the nitrite test can be negative even when bacteria are present. Bacteria like Staphylococcus saprophyticus, Enterococcus, and some Klebsiella strains don't convert nitrate at all, so those infections will always test nitrite-negative. For anyone with symptoms but a negative dipstick, a urine culture is the next step.
Microscopic Urinalysis
Microscopic urinalysis goes further than the dipstick — a lab technician places a centrifuged sample of your urine under a microscope and directly counts what's there. It takes a few hours at most hospitals but provides much more detailed information.
What the lab counts and what it means:
- White blood cells (WBCs): Normal urine has zero to four WBCs per high-power microscope field. When infection is present, the immune system floods the urinary tract with neutrophils. Finding five or more WBCs per high-power field is called pyuria and is one of the strongest indicators of active infection. The higher the count, the more likely a true infection (as opposed to contamination).
- Bacteria: Lab technicians can directly see bacteria in the urine sample. Even one bacterium per high-power field typically represents significant bacterial counts in the original sample. Seeing many bacteria alongside pyuria makes infection highly likely.
- Casts: Casts are cylindrical protein structures that form inside the tiny tubules of your kidneys. They are shaped by the tubule walls and then washed out in urine. White blood cell casts — cylinders containing trapped white blood cells — are an important sign that the infection has reached the kidneys. Finding WBC casts during a UTI evaluation tells your doctor this is not just a bladder infection: the kidneys are involved, which means pyelonephritis (kidney infection) and a longer course of antibiotics is needed.
When doctors order microscopy vs. just a dipstick: In a straightforward first UTI in a young healthy woman with classic symptoms (burning, frequency, urgency), many guidelines allow empiric treatment based on symptoms alone or a positive dipstick without microscopy. But microscopy becomes important when the dipstick is borderline, when the patient is pregnant or elderly, when there are symptoms suggesting kidney involvement (flank pain, fever, shaking chills), or when the diagnosis is genuinely uncertain. Microscopy adds cost and time, so it's used when the clinical picture demands more information.
Urine Culture: The Gold Standard
A urine culture is the most definitive test for a urinary tract infection. It tells you exactly which bacteria is causing the infection and which antibiotics will actually kill it. Every other test is a proxy — the culture is the real answer.
How to collect the sample properly — the midstream clean-catch: How you collect urine matters enormously, because urine passes through areas that naturally harbor bacteria on the skin. If you just urinate into a cup, you'll contaminate the sample with those normal skin bacteria, making results difficult to interpret. The correct technique:
- Wash your hands.
- Clean the opening of the urethra with provided antiseptic wipes (front to back for women).
- Begin urinating into the toilet — this "first stream" flushes out bacteria from the outer urethra.
- Without stopping, move the collection cup into the stream and collect the "midstream" portion.
- Remove the cup, finish urinating into the toilet, and seal the cup immediately.
- The sample should reach the lab within two hours, or be refrigerated.
What the results mean:
- ≥100,000 CFU/mL (colony-forming units per milliliter) of a single bacterial species in a clean-catch sample from a woman is the classic threshold for a significant infection. CFU/mL measures bacterial density — 100,000 means roughly 100,000 individual bacteria per milliliter of your urine.
- ≥1,000 CFU/mL counts as significant in a symptomatic woman — if you have burning and urgency, lower bacterial counts are still meaningful. Studies show that many real UTIs in young women have counts between 1,000 and 100,000 CFU/mL.
- Men: Any count ≥1,000 CFU/mL from a properly collected sample is considered clinically significant in a symptomatic man, since men rarely have urinary bacteria otherwise.
- Multiple organisms: When the culture grows three or more different bacteria, it almost always means contamination during collection — the report will usually say "mixed flora, likely contamination," and a repeat clean-catch is needed.
Antibiotic susceptibility testing: Once bacteria grow on the culture plate, the lab performs susceptibility testing — exposing the bacteria to panels of antibiotics and measuring whether they grow or are killed. The report your doctor receives lists each antibiotic as:
- S (Susceptible): Standard doses of this antibiotic should clear this infection.
- I (Intermediate / Susceptible, increased exposure): May work if given at higher doses or if it concentrates in the infection site (like urine).
- R (Resistant): This antibiotic is unlikely to work and should not be used.
Results typically come back in 24 to 48 hours. Your doctor may start an antibiotic immediately based on your symptoms and local resistance patterns, then adjust (or stop) when culture results return — this is called "antibiotic stewardship" and is important for not breeding resistant bacteria.
When to Get a Urine Culture vs. Just Treat
Not every person with UTI symptoms needs a urine culture before starting antibiotics. But some situations absolutely require one. Here's how doctors think about it:
Situations where empiric treatment without a culture is reasonable:
- Young, healthy, non-pregnant woman with classic, uncomplicated UTI symptoms (burning, frequency, urgency — no fever, no flank pain)
- First UTI or infrequent UTI (less than two per year)
- No recent antibiotic use in the past three months (which would raise concern for resistance)
- No known ESBL or resistant E. coli in prior cultures
In these cases, guidelines from the Infectious Diseases Society of America (IDSA) support treating based on symptoms and local resistance data without waiting for a culture.
Situations where a culture is always indicated:
- Pregnant women: Even without symptoms, bacteriuria (bacteria in the urine) during pregnancy carries real risk of premature birth and kidney infection. Culture-based screening is standard at the first prenatal visit.
- Men: UTIs in men are uncommon and often signal an underlying structural problem (enlarged prostate, kidney stone, urinary tract abnormality). A culture is always needed.
- Complicated UTIs: Fever, flank pain, or suspicion of kidney involvement; recent urological procedure; urinary catheter in place; kidney transplant or immunosuppression; diabetes.
- Treatment failure: If symptoms haven't improved after 48 to 72 hours on antibiotics, you need a culture — you may have a resistant organism that isn't responding to the drug chosen.
- Recurrent UTIs: Two or more UTIs in six months, or three or more in a year. A culture helps identify whether you're being re-infected with a new strain or whether the same strain persists because it developed resistance.
- Hospitalized patients: Hospital-acquired UTIs involve different bacterial species and resistance patterns than community-acquired infections. Culture is always required.
Stool Culture for STEC and Intestinal E. coli
When someone has severe bloody diarrhea, vomiting, and abdominal cramps — especially after eating undercooked meat, unpasteurized produce, or during a known outbreak — doctors must test for Shiga toxin-producing E. coli (STEC), particularly the dangerous O157:H7 strain that causes hemolytic uremic syndrome (HUS).
The critical laboratory problem: Standard stool cultures use a general-purpose agar that grows many bacteria — but they are often designed to detect Salmonella and Shigella, not E. coli O157:H7. Here's why this matters: most E. coli strains ferment sorbitol (a sugar alcohol) quickly, turning the indicator dye in sorbitol-MacConkey agar pink or red. But E. coli O157:H7 cannot ferment sorbitol — it shows up as pale, colorless colonies on that specialized agar, making it easy to spot against the background of normal fermenters. If you request a standard stool culture, the lab may simply plate your sample on standard media and report "normal flora" — completely missing the O157:H7 strain that is quietly growing there.
What to tell your doctor and the lab: If you have bloody diarrhea and a possible exposure (undercooked beef, raw produce, farm animals, a known outbreak in your area), specifically request testing for "STEC" or "E. coli O157". Instruct the lab to use Sorbitol-MacConkey (SMAC) agar. This single conversation can be the difference between a correct diagnosis and a missed one.
Timing matters: STEC is most reliably detected in stool within 48 to 72 hours of the onset of bloody diarrhea. After several days, bacterial shedding drops significantly and the test becomes much less sensitive. Don't wait. If you have bloody diarrhea and suspect contaminated food, go in immediately and push for STEC-specific testing.
For diarrheal E. coli strains other than O157 (such as ETEC causing traveler's diarrhea, or EPEC in infants), standard lab testing is rarely helpful in outpatient settings because most mild cases resolve without identifying the exact strain. Testing is typically reserved for outbreak investigation, severely ill patients, and returning travelers who are getting worse rather than better.
Shiga Toxin Immunoassay (EIA)
The Shiga toxin enzyme immunoassay (EIA) is a faster, more sensitive approach to detecting STEC than bacterial culture alone — and it is now the first-line test recommended by the U.S. Centers for Disease Control and Prevention (CDC) for patients with bloody diarrhea.
How it works: Instead of trying to grow and identify bacteria, this test detects the toxin itself — Shiga toxin 1 (Stx1) or Shiga toxin 2 (Stx2), or both. The assay uses antibodies bound to a detection surface. If Shiga toxin is present in your stool sample, it binds to those antibodies and triggers a color change or fluorescent signal. The test can be completed in a few hours, far faster than waiting 24 to 48 hours for bacterial cultures to grow.
Performance: The Shiga toxin EIA has approximately 90% sensitivity for detecting STEC infection when tested on a fresh stool sample. Specificity is similarly high — a positive result reliably indicates STEC infection. Critically, this test detects all STEC serotypes, not just O157:H7, including the non-O157 strains (O26, O103, O111, O121, O145) that are increasingly responsible for severe outbreaks but are easily missed by O157-specific culture methods.
What a positive result means for your care: A positive Shiga toxin EIA immediately changes your management. Your doctor will:
- Withhold antibiotics entirely (they increase HUS risk — see the Treatment section)
- Admit you or watch you very closely for signs of HUS (decreasing urine output, unusual bruising, extreme fatigue)
- Avoid anti-motility drugs like loperamide (Imodium), which prolong bacterial time in the gut and may worsen toxin absorption
- Report the case to public health authorities for outbreak investigation
Best practice is to run the Shiga toxin EIA alongside SMAC agar culture — the EIA catches all toxin-producing strains rapidly, while the culture provides bacterial isolates that public health labs need for outbreak typing and epidemiological tracking.
Blood Cultures for Suspected Sepsis
When E. coli escapes the urinary tract or intestines and enters the bloodstream, it causes bacteremia — bacteria circulating in the blood. If the immune system cannot quickly contain this, it can escalate to sepsis, a life-threatening cascade of organ dysfunction. Blood cultures are the test that detects this.
When blood cultures are ordered: The clinical picture that prompts blood cultures includes high fever (above 38.5°C / 101.3°F), shaking chills (rigors), low blood pressure, rapid heart rate, or altered mental status — especially in someone who already has a UTI or recent urological procedure. Elderly patients and people on immunosuppressive medications can have sepsis without all the classic signs; any unexplained deterioration warrants blood cultures.
The technique — why two sets matter: Blood cultures are always collected as two sets from two different venipuncture sites (for example, one from the left arm and one from the right arm), drawn within minutes of each other. Each set has an aerobic bottle and an anaerobic bottle, for four bottles total. This matters because:
- Two sets dramatically improve the sensitivity of detection — a single set misses up to 20% of true bacteremias.
- Comparing both sets helps distinguish true bacteremia from contamination. A contaminant (like skin bacteria picked up during the draw) usually grows in only one bottle. A true pathogen grows in multiple bottles.
- Blood cultures must be drawn before antibiotics start whenever possible — even a single dose of antibiotics can suppress bacterial growth and produce a false-negative result.
Results and timeline: Modern blood culture systems use automated broth incubators that continuously monitor for bacterial growth by detecting carbon dioxide production. A positive blood culture typically signals an alarm within 24 to 72 hours. The lab will perform a rapid Gram stain (which tells you "gram-negative rods" = likely E. coli within hours of the alarm), followed by species identification and susceptibility testing over the next 12 to 24 hours.
What bacteremia means for your treatment: E. coli bacteremia is a serious diagnosis requiring intravenous antibiotics, usually in the hospital. If you have a known source (a UTI that is draining into the blood, an infected kidney stone blocking urine flow, an infected intravenous catheter), addressing that source is as important as the antibiotic itself — antibiotics cannot clear an infection if pus is trapped or if a foreign body is seeding bacteria continuously into the blood. Source control — draining abscesses, removing infected catheters, unblocking obstructed kidneys — is often the critical intervention alongside antibiotics.
Detecting ESBL and Resistant E. coli in the Lab
Extended-spectrum beta-lactamase (ESBL) producing E. coli is one of the most important antimicrobial resistance problems in the world today. ESBL enzymes allow bacteria to destroy most penicillins and cephalosporins — a wide swath of commonly used antibiotics. Detecting them accurately in the clinical microbiology lab is essential because a susceptibility report that says "S" (susceptible) to a cephalosporin can be dangerously misleading when ESBL enzymes are present.
How labs identify ESBL producers:
- Combination disk test (CDT): The standard phenotypic screening method. The lab places disks of a third-generation cephalosporin (cefotaxime or ceftazidime) alongside disks of that same cephalosporin combined with clavulanate (a beta-lactamase inhibitor) on an agar plate. If the bacteria grow closer to the plain cephalosporin disk but are inhibited by the cephalosporin-plus-clavulanate combination (the inhibitor zone is noticeably larger), an ESBL is present. The difference in zone size must be at least 5mm to call it ESBL-positive.
- E-test (gradient strip method): A continuous antibiotic concentration gradient along a plastic strip placed on agar. The strip has plain cephalosporin on one end and cephalosporin-plus-clavulanate on the other. The ratio between the two MIC (minimum inhibitory concentration) values reveals ESBL activity. Highly reliable and used as a confirmatory test.
- PCR for resistance genes: Molecular testing can directly identify the specific genes encoding ESBL enzymes — CTX-M, SHV, TEM being the most common. PCR is faster than culture-based methods and is increasingly used in outbreak investigations, infection control, and research. Some hospitals now use rapid molecular panels that can detect resistance genes directly from positive blood culture bottles within hours of the alarm, dramatically shortening the time to appropriate treatment.
Understanding the susceptibility report:
- S (Susceptible): Standard doses of this antibiotic should work.
- I (Intermediate / Susceptible, increased exposure): May work with higher doses or at a site where the drug concentrates (like urine).
- R (Resistant): Do not use this antibiotic.
The critical trap with ESBLs and cephalosporins: Current CLSI and EUCAST standards require that when an E. coli isolate is confirmed to produce ESBLs, the lab must report all penicillins and cephalosporins as resistant — regardless of what the disk diffusion result looks like. This is called "categorical change" or "suppression of susceptible results." Older laboratory systems without this rule could report an ESBL-producing E. coli as "susceptible" to ceftriaxone based on the disk zone, leading to treatment failure. If your microbiology lab has identified your E. coli as ESBL-positive, do not expect any cephalosporin antibiotic to work, even if an old report said susceptible — those disk results are unreliable for ESBL strains.
For patients with documented ESBL infections, your doctor will almost certainly switch to a carbapenem antibiotic (meropenem, ertapenem) for serious infections, or use nitrofurantoin or fosfomycin for uncomplicated UTIs if susceptibility testing confirms these agents work against your specific strain.
Key Research Papers
- Dielubanza E.J. & Schaeffer A.J. (2011). Urinary tract infections in women. Medical Clinics of North America. PMID: 28224854
- Simerville J.A. et al. (2005). Urinalysis: a comprehensive review. American Family Physician. PMID: 24819360
- Lichtenberger P. & Hooton T.M. (2008). Complicated urinary tract infections. Current Infectious Disease Reports. PMID: 19364969
- Gupta K. et al. (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. Clinical Infectious Diseases. PMID: 22848250
- Banatvala N. et al. (1996). The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. Journal of Infectious Diseases. PMID: 27609610
- Tarr P.I. (2009). Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. JAMA. PMID: 25832108
- Pitout J.D. (2007). Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. PMID: 17702726
- Paterson D.L. & Bonomo R.A. (2005). Extended-spectrum beta-lactamases: a clinical update. Clinical Microbiology Reviews. PMID: 18039774
Connections
- E. coli Symptoms & Infections Hub
- Intestinal E. coli and STEC
- E. coli UTI Symptoms
- Antibiotic Treatment for E. coli
- ESBL and Carbapenem Resistance
- Lab Tests Overview
- All Bacterial Infections